Io Biotech Inc
(IOBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,747 | 117,982 | 143,193 | 165,501 | 110,095 |
| TOTAL | $107,652 | $124,128 | $147,255 | $168,254 | $113,036 |
| Non-Current Assets | |||||
| PPE Net | 735 | 788 | 847 | 797 | 826 |
| Other Non-Current Assets | 3,080 | 3,243 | 2,616 | 3,502 | 3,693 |
| TOTAL | $3,815 | $4,031 | $3,463 | $4,299 | $4,519 |
| Total Assets | $111,467 | $128,159 | $150,718 | $172,553 | $117,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,016 | 3,840 | 3,878 | 6,645 | 4,464 |
| Accrued Expenses | 8,029 | 6,537 | 11,184 | 5,713 | 5,799 |
| TOTAL | $13,723 | $11,043 | $15,717 | $12,985 | $10,876 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,472 | 1,650 | 1,839 | 1,976 | 2,159 |
| TOTAL | $1,472 | $1,650 | $1,839 | $1,976 | $2,159 |
| Total Liabilities | $15,195 | $12,693 | $17,556 | $14,961 | $13,035 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,881 | 65,881 | 65,881 | 65,881 | 65,881 |
| Common Shares | 66 | 66 | 66 | 66 | 29 |
| Retained earnings | -303,965 | -283,279 | -263,822 | -237,640 | -215,961 |
| Other shareholders' equity | -9,626 | -9,475 | -9,669 | -9,873 | -9,765 |
| TOTAL | $96,272 | $115,466 | $133,162 | $157,592 | $104,520 |
| Total Liabilities And Equity | $111,467 | $128,159 | $150,718 | $172,553 | $117,555 |